IND clearance marks the first ever cellular rejuvenation therapy using partial epigenetic reprogramming to reach human ...

Vision often worsens early in nonarteritic anterior ischemic optic neuropathy, and a past episode in the other eye predicts the decline but common cardiovascular factors do not, a study finds.

Millions of people are now using weight-loss drugs, but it seems there are side-effects that come with the slimmer waistlines ...

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...

Optic neuritis, a common multiple sclerosis symptom, causes vision loss due to optic nerve inflammation. This experimental therapy aims to protect vision and nerve structure; a global Phase 3 trial is ...

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

FRANKLIN, Ind. — When Elizabeth Wilde Gestner woke up one morning in September 2024, something wasn’t right. She could not see out of most of her right eye. There was no warning. No physical pain.

ORLANDO -- Adding another twist to the ongoing debate about the effects of weight-loss drugs on vision, a retrospective cohort study linked GLP-1 receptor agonists to a lower risk of legal blindness ...

ZUG, Switzerland, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic diseases with significant ...